New Class of Biomarkers Predicts Cancer Patient Treatment Response
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Hematology & Serology, Lung Cancer |
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Chris Wolski | May 17, 2023 | Hematology & Serology |
In a world where routine diagnostic tests are the norm, it is often forgotten that a lab test can be a lifesaver.
Read MorePosted by Melanie Hamilton-Basich | May 8, 2023 | Digital Imaging |
Siemens Healthineers has entered into an agreement to distribute Scopio Labs’ full-field digital cell morphology technology, which will enable clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2023 | Hematology & Serology |
A new agreement allows Werfen to continue offering HemoCell Specialized Lab Automation, with its large installed base of hemostasis automation workcells.
Read MorePosted by Melanie Hamilton-Basich | May 1, 2023 | Company News |
In addition to expanding its facility, MCI Diagnostic Center is launching a recruitment campaign seeking candidates for every department.
Read More